Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats

Life Sciences

Volumn 89, Issue 19-20, 2011, Pages 717-724

  Kolouchova, Gabriela ^a   Brcakova, Eva ^a,b   Hirsova, Petra ^a   Cermanova, Jolana ^a   Fuksa, Leos ^a   Mokry, Jaroslav ^a   Nachtigal, Petr ^b   Lastuvkova, Hana ^a   Micuda, Stanislav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Cholestasis; Ferroportin 1; Hepcidin; Iron; Keywords; Pravastatin

Indexed keywords

CD71 ANTIGEN; FERRITIN; FERROPORTIN 1; HEME OXYGENASE 1; HEPCIDIN; IRON; LIVER PROTEIN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PRAVASTATIN; SODIUM CHLORIDE; TRANSFERRIN RECEPTOR 2;

ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BIOCHEMISTRY; CHOLESTASIS; CONTROLLED STUDY; HYPERBILIRUBINEMIA; IRON BLOOD LEVEL; IRON METABOLISM; LIVER PARENCHYMA; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CHOLESTASIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IRON; LIVER; MALE; PRAVASTATIN; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 80054993346     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.08.014     Document Type: Article

References (29)

1. B. Aksu, H. Umit, M. Kanter, A. Guzel, C. Aktas, and S. Civelek Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats Acta Histochem 112 2010 259 269
2. B. Arezzini, B. Lunghi, G. Lungarella, and C. Gardi Iron overload enhances the development of experimental liver cirrhosis in mice Int J Biochem Cell Biol 35 2003 486 495
3. A.S. Awad, and R. Kamel Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers J Biochem Mol Toxicol 24 2010 89 94
4. A.G. Barbeito, H.J. Garringer, M.A. Baraibar, X. Gao, M. Arredondo, and M.T. Nunez Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene J Neurochem 109 2009 1067 1078
5. E. Brcakova, L. Fuksa, J. Cermanova, G. Kolouchova, M. Hroch, and P. Hirsova Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats Biol Pharm Bull 32 2009 1978 1985
6. J.C. Canzoneri, and A.K. Oyelere Interaction of anthracyclines with iron responsive element mRNAs Nucleic Acids Res 36 2008 6825 6834
7. I. De Domenico, D.M. Ward, and J. Kaplan Hepcidin regulation: ironing out the details J Clin Invest 117 2007 1755 1758
8. S. Demirbilek, E. Tas, K. Gurunluoglu, M. Akin, R.T. Aksoy, and M.H. Emre Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis Pediatr Surg Int 23 2007 155 162
9. S. Dold, M.W. Laschke, S. Lavasani, M.D. Menger, B. Jeppsson, and H. Thorlacius Simvastatin protects against cholestasis-induced liver injury Br J Pharmacol 156 2009 466 474
10. M. Froh, L. Conzelmann, P. Walbrun, S. Netter, R. Wiest, and M.D. Wheeler Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats World J Gastroenterol 13 2007 3478 3486
11. D. Galaris, and K. Pantopoulos Oxidative stress and iron homeostasis: mechanistic and health aspects Crit Rev Clin Lab Sci 45 2008 1 23
12. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources. National Academy Press, Washington, D.C., 1996.
13. Y.H. Huang, J.H. Chuang, Y.L. Yang, C.C. Huang, C.L. Wu, and C.L. Chen Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling Lab Invest 89 2009 1128 1139
14. Y.H. Huang, H. Yu-Hsieh, C.C. Huang, V.T. Shin-Mu, M.H. Tai, and C.L. Chen Liver hepcidin and stainable iron expression in biliary atresia Pediatr Res 59 2006 662 666
15. T. Kurihara, M. Akimoto, K. Abe, H. Ishiguro, A. Niimi, and A. Maeda Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia Clin Ther 15 1993 890 898
16. S. Micuda, L. Fuksa, L. Mundlova, J. Osterreicher, J. Mokry, and J. Cermanova Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly Clin Exp Pharmacol Physiol 34 2007 296 303
17. L. Muchova, R.J. Wong, M. Hsu, I. Morioka, L. Vitek, and J. Zelenka Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection Can J Physiol Pharmacol 85 2007 800 810
18. M. Munoz, I. Villar, and J.A. Garcia-Erce An update on iron physiology World J Gastroenterol 15 2009 4617 4626
19. K. Otogawa, T. Ogawa, R. Shiga, K. Nakatani, K. Ikeda, and Y. Nakajima Attenuation of acute and chronic liver injury in rats by iron-deficient diet Am J Physiol Regul Integr Comp Physiol 294 2008 R311 R320
20. G. Papanikolaou, and K. Pantopoulos Iron metabolism and toxicity Toxicol Appl Pharmacol 202 2005 199 211
21. G. Peretz, G. Link, O. Pappo, R. Bruck, and Z. Ackerman Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease World J Gastroenterol 12 2006 240 245
22. S.J. Peterson, W.H. Frishman, and N.G. Abraham Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system Cardiol Rev 17 2009 99 111
23. A. Pietrangelo Hepcidin in human iron disorders: therapeutic implications J Hepatol 54 2011 173 181
24. A. Pietrangelo Metals, oxidative stress, and hepatic fibrogenesis Semin Liver Dis 16 1996 13 30
25. S. Scheingraber, M. Bauer, I. Bauer, D. Bardens, K. Abel, and A.K. Horn Inhibition of hemoxygenase-1 improves survival after liver resection in jaundiced rats Eur Surg Res 42 2009 157 167
26. K.A. Stuart, G.J. Anderson, D.M. Frazer, T.L. Murphy, L.W. Powell, and L.M. Fletcher Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis Hepatology 39 2004 492 499
27. J. Trebicka, M. Hennenberg, M. Odenthal, K. Shir, S. Klein, and M. Granzow Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells J Hepatol 53 2010 702 712
28. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
29. K.Y. Yeh, M. Yeh, and J. Glass Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat Am J Physiol Gastrointest Liver Physiol 286 2004 G385 G394